Safety & Efficacy of BCT197A2201 in COPD patients presenting with an exacerbation

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-021723-27

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

• To assess the efficacy of a single and repeated dose of BCT197 in COPD patients presenting with an exacerbation measured by the improvement in FEV1 over the first 5 days of treatment relative to placebo, and over the first 10 days in Parts III and IV.


Critère d'inclusion

  • Acute COPD exacerbations

Liens